Genmab | GEN - Interest Income


Genmab reported DKK14M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Agios Pharmaceuticals USD 10.8M 1.62M Mar/2026
Almirall EUR 2.71M 580K Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
argenx SE USD 44M 874K Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Bayer EUR 169M 39M Dec/2025
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Exelixis USD 14.21M 1.92M Jun/2026
Fresenius Medical Care EUR 14.7M 77K Jun/2026
Genmab DKK 14M 11M Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
GN Store Nord DKK 99M 251M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Insmed USD 765K 55K Sep/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 36M 15M Mar/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026